Skip to main content
SpringerLink
Log in

Correcting QT for Heart Rate When Both are Affected by a Drug

  • Commentary
  • Published:
Drug Safety Aims and scope Submit manuscript

The Original Article was published on 25 September 2018

The Original Article was published on 25 September 2018

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. If a log-linear correction is used, this in fact would be an exponent, but, in agreement with common practice, the term ‘correction factor’ is used throughout.

References

  1. ICH E14 guideline. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. 2005. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E14/E14_Guideline.pdf. Accessed 2 Nov 2018.

  2. Fridericia LS. Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken. Acta Med Scand. 1920;53:469–86.

    Article  Google Scholar 

  3. Garnett CE, Zhu H, Malik M, Fossa AA, Zhang J, Badilini F, et al. Methodologies to characterize the QT/corrected QT interval in the presence of drug-induced heart rate changes or other autonomic effects. Am Heart J. 2012;163(6):912–30.

    Article  PubMed  Google Scholar 

  4. Malik M, Garnett C, Hnatkova K, Vicente J, Johannesen L, Stockbridge N. Implications of individual QT/RR profiles – Part 1: inaccuracies and problems of population-specific QT/heart rate corrections. Drug Saf. 2018. https://doi.org/10.1007/s40264-018-0736-1 (Epub 2018 Sep 25).

    Article  PubMed Central  Google Scholar 

  5. Malik M, Garnett C, Hnatkova K, Vicente J, Johannesen L, Stockbridge N. Implications of individual QT/RR profiles—Part 2: zero QTc/RR correlations do not prove QTc correction accuracy in studies of QTc changes. Drug Saf. 2018. https://doi.org/10.1007/s40264-018-0735-2 (Epub 2018 Sep 25).

    Article  PubMed Central  Google Scholar 

  6. Franz MR, Schaefer J, Schöttler M, Seed WA, Noble MI. Electrical and mechanical restitution of the human heart at different rates of stimulation. Circ Res. 1983;53:815–22.

    Article  CAS  PubMed  Google Scholar 

  7. Pueyo E, Smetana P, Laguna P, Malik M. Estimation of the QT/RR hysteresis lag. J Electrocardiol. 2003;36(Suppl):187–90.

    Article  PubMed  Google Scholar 

  8. Mendzelevski B, Ferber G, Janku F, Li BT, Sullivan RJ, Welsch D, et al. Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignancies. Cancer Chemother Pharmacol. 2018;81(6):1129–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Wang Y, Pan G, Balch A. Bias and variance evaluation of QT interval correction methods. J Biopharm Stat. 2008;18(3):427–50.

    Article  PubMed  Google Scholar 

  10. Dang Q, Zhang J. Validation of QT interval correction methods when a drug changes heart rate. Ther Innov Regul Sci. 2013;47(2):256–60.

    PubMed  Google Scholar 

  11. Tornøe CW, Garnett CE, Wang Y, Florian J, Li M, Gobburu JV. Creation of a knowledge management system for QT analyses. J Clin Pharmacol. 2011;51(7):1035–42.

    Article  PubMed  Google Scholar 

  12. Malik M, Garnett C, Hnatkova K, Johannesen L, Vicente J, Stockbridge N. Importance of QT/RR hysteresis correction in studies of drug-induced QTc interval changes. J Pharmacokinet Pharmacodyn. 2018;45(3):491–503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

I would like to thank Börje Darpö, Randy Brown, and their colleagues from ERT for many helpful discussions on the topic.

Author information

Authors and Affiliations

  1. Statistik Georg Ferber GmbH, Cagliostrostrasse 14, 4125, Riehen, Switzerland

    Georg Ferber

Authors
  1. Georg Ferber
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Georg Ferber.

Ethics declarations

Conflict of interest

Georg Ferber reports no conflicts of interest.

Funding

Georg Ferber did not receive any funding for this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ferber, G. Correcting QT for Heart Rate When Both are Affected by a Drug. Drug Saf 42, 335–337 (2019). https://doi.org/10.1007/s40264-018-0749-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40264-018-0749-9

Search

Navigation